Kazumi Iwaki

Title: Kazumi Iwaki: Innovator in Pharmaceutical Chemistry

Introduction

Kazumi Iwaki is a notable inventor based in Higashiosaka, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address critical health issues.

Latest Patents

Kazumi Iwaki holds 2 patents related to benzothiazepine derivatives. These compounds are designed to treat hypertension and cardiac diseases. The first patent describes a compound of the formula: ##STR1## wherein X is .dbd.N--A--R.sup.1 or .dbd.C(R.sup.1)R.sup.2; A is a single bond, polymethylene, or --CO--; R.sup.1 and R.sup.2 are each hydrogen, C.sub.1-6 alkyl, C.sub.3-7 cycloalkyl, unsubstituted or substituted phenyl, optionally substituted benzhydryl, or optionally substituted 5 to 6 membered heterocyclic group. The second patent outlines a similar compound with variations in the substituents, emphasizing its pharmaceutical applications.

Career Highlights

Kazumi Iwaki is currently associated with Shionogi Company Limited, where she continues her research and development efforts. Her work has been instrumental in advancing therapeutic options for patients suffering from cardiovascular conditions.

Collaborations

Kazumi has collaborated with notable colleagues, including Teruo Yamamori and Katsunori Sakai, who have contributed to her research endeavors.

Conclusion

Kazumi Iwaki's innovative work in pharmaceutical chemistry highlights her commitment to improving healthcare through her inventions. Her contributions to the field are invaluable and continue to impact the treatment of hypertension and cardiac diseases.